Hicon Solution
Product Images NDC 65174-880

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Hicon (NDC 65174-880). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Image01)

An instructional illustration showing a person using their thumb and forefinger of one hand to hold a small cylindrical object, with the thumb and forefinger of the other hand pinch-holding the opposite end, suggesting handling or dispensing a small oral container or vial, related to the HICON Sodium Iodide I 131 oral solution product.*

FDA Label Image

Image Description (Image02)

An instructional illustration showing a person holding a capsule with both hands, preparing to open it by pulling apart the two halves. The image focuses on manual manipulation of the capsule, possibly demonstrating how to open it before administration.*

FDA Label Image

Image Description (Image03)

An instructional illustration depicting a syringe inserting into the top of a vial containing a solution. The vial is shown inside a circular container, suggesting a preparation step for an oral solution, consistent with radiopharmaceutical handling.*

FDA Label Image

Image Description (Image04)

An instructional illustration showing a syringe drawing liquid from a vial placed in a circular holder with multiple compartments, likely depicting preparation steps for the HICON (Sodium Iodide I 131) oral solution.*

FDA Label Image

Image Description (Image05)

An instructional diagram illustrating the placement or removal of vial caps or stoppers from a vial. The image shows three vial stoppers standing upright and one being lifted off a vial, indicated by an arrow, demonstrating a step in vial handling or preparation.*

FDA Label Image

Label 1

Label for HICON Sodium Iodide I 131 solution, USP, 1,000 mCi/mL. The label includes lot number 2270252-0, expiration date 04/APR/2022, and is manufactured by Jubilant DraxImage Inc. A radiation symbol is visible on the label.*

FDA Label Image

Label 2

Label for HICON Sodium Iodide I 131 Solution, USP, 1000 mCi/mL, oral solution by Jubilant DraxImage Inc. The label shows radioactive material caution, lot number 2270252-2, total activity 250 mCi in 0.25 mL volume, calibration date 26/MAR/2022, and expiry 04/APR/2022. Storage instructions specify 2°C to 25°C (36°F to 77°F). It includes the NDC 65174-880-25 and manufacturing details from Kirkland, Quebec, Canada.*

FDA Label Image

Label 3

Label for HICON Sodium Iodide I 131 Solution, USP, 1000 mCi/mL, oral solution. It states a total activity of 500 mCi in 0.50 mL volume, with a radioactive concentration of 37,000 MBq/mL (1,000 mCi/mL). The label includes calibration date 26/MAR/2022, expiry 04/APR/2022, and storage instructions between 2°C and 25°C. Manufacturer is Jubilant DraxImage Inc., dba Jubilant Radiopharma, Kirkland, Quebec, Canada. The label cautions this is radioactive material.*

FDA Label Image

Label 6

Label for HICON Sodium Iodide I 131 Solution, USP, 1000 mCi/mL, 1.00 mL oral solution. The label includes lot number 2270252-0, total activity 1,000 mCi, radioactive concentration 37,000 MBq/mL, calibration date 26/MAR/2022, and expiry date 04/APR/2022. It warns "Caution Radioactive Material" and indicates it is manufactured by Jubilant DraxImage Inc., dba Jubilant Radiopharma, Kirkland, Quebec, Canada. Storage instructions specify 2°C to 25°C.*

FDA Label Image

Logo

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.